Withdrawal of sibutramine in Europe

BMJ (Online)

Volumn 340, Issue 7743, 2010, Pages 377-

  Williams, Gareth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG MARKETING; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; EUROPE; HUMAN; MORBIDITY; OBESITY; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; APPETITE DEPRESSANTS; CARDIOVASCULAR DISEASES; CYCLOBUTANES; EUROPE; HUMANS; MIDDLE AGED; OBESITY; SAFETY-BASED DRUG WITHDRAWALS;

EID: 77149170351     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c824     Document Type: Editorial

References (9)

1. European Medicines Agency. Press release 21 January 2010. www.ema.europa.eu/pdfs/human/referral/sibutramine/3940810en.pdf.
2. Ajani UA, Lotufo PA, Gaziano JM. Body mass index and mortality among US male physicians. Ann Epidemiol 2004;14:731-9.[CrossRef][Web of Science][Medline]
3. Ryan D. Risks and benefits of weight loss: challenges to obesity research. Eur Heart J 2005;7(suppl L):L27-31.[CrossRef]
4. Wilding JPH. Pharmacological approaches for treating obesity. In: Williams G, Frühbeck G, eds. Obesity: science to practice. Wiley-Blackwell, 2009:421-6.
5. Von Haehling S, Lainscak M, Anker SD. Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon? Eur Heart J 2007;28:2830-1.[Free Full Text]
6. Diaz A, Bourassa MG, Guertin M-C, Tardif J-C. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary heart disease. Eur Heart J 2005;26:967-4. [Abstract/Free Full Text]
7. James WPT. The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients. Eur Heart J 2005;7(suppl L):L44-8.[CrossRef]
8. Coleman E. Anorectics on trial. A half century of federal regulation of prescription appetite suppressants. Ann Intern Med 2005;143:380-5. [Abstract/Free Full Text]
9. Higgins M, D'Agostino R, Kannel W, Cobb J. Benefits and adverse effects of weight loss. Observations from the Framingham Study. Ann Intern Med 1993;119:758-63.[Abstract/Free Full Text]